Options Trading News

December 30, 2011  Fri 12:16 PM CT

Keryx Biopharmaceuticals is bouncing today, and one investor is using an unusual strategy to ride the move.

optionMONSTER's tracking programs detected the sale of 2,000 February 3 puts for $0.65. There was no previous open interest in the strike before the trade occurred, indicating that this is a new position.

KERX is up 8.4 percent to $2.58 in early afternoon trading, making the puts in the money. Their value will move in the opposite direction as the shares and, because this is a short-term play, the trader will profit if the stock pushes higher.  

The effective entry price is $2.35 because of the credit earned, so the position would make money even if KERX holds its ground. The strategy is interesting because it allows the investor to manage a long position in the drug developer without having to time precisely their entry point.
(See related column by CHris McKhann)

Overall option volume in the name is about triple the daily average so far today.
Share this article with your friends


Premium Services

Archived Webinar

Education & Strategy

The covered call and unhedged risk

I have written a few things on the Covered Call Strategy over the last two weeks. Please understand that those two previous articles plus this one do not constitute a proper, fully in-depth lesson on the Covered Call Strategy like we have in our classes at Option Monster Education. I have picked out a few topics that I believe were worth noting and today I am going to add the final one.

View more education articles »